FOX vs PRLD · P/E 13, rev $16.30B vs rev $6.5M
Fox Corp Class B (FOX) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the FOX and PRLD stock pages for the full models.
Not investment advice.